A new study from the American College of Cardiology has found that the popular ketogenic or "keto" diet may contribute to higher levels of "bad cholesterol" and a twofold increase in the risk of heart attacks and strokes.
“Our study found that regular consumption of a self-reported diet low in carbohydrates and high in fat was associated with increased levels of LDL cholesterol— or “bad” cholesterol—and a higher risk of heart disease,” said Dr. Iulia Iatan, MD, PhD, lead author of the study and attending physician-scientist at the Healthy Heart Program Prevention Clinic in St. Paul’s Hospital.
“To our knowledge, our study is one of the first to examine the association between this type of dietary pattern and cardiovascular outcomes.”
The study points out that depriving the body of carbohydrates such as bread, pasta, and rice forces the body to break down fat for energy instead. This breakdown produces ketones in the liver, hence the name keto. Advocates for this type of diet suggest obtaining 60 to 80 percent of calories from fat.
By comparing this low-carbohydrate, high-fat (LCHF) diet with a more standard diet, the study found that it elevated levels of LDL cholesterol in some people, which is known to elevate the risk of heart disease.
Before starting this dietary pattern, they should consult a healthcare provider," Iatan said. "While on the diet, it is recommended they have their cholesterol levels monitored and should try to address other risk factors for heart disease or stroke, such as diabetes, high blood pressure, physical inactivity and smoking.”
The Bill Gates-founded Breakthrough Energy company invested $80 million in Verdox Inc. to facilitate efficient, lower-cost technolog to remove carbon from the air and emission sources. CEO of Verdox, Brian Baynes, joined Cheddar News to discuss the investment, how the company's tech works, and where he sees it going. "We anticipate that with technologies like ours, we potentially can get to the scale of about a million tons per year within 5-10 years," he said. "And then ultimately we need to be doing this at the scales of billions of tons per year and ultimately about 10 billion tons per year in the year 2050."
As the Russia's invasion of Ukraine continues, medical experts are worried conditions in active warzones will exacerbate the current pandemic — or even give rise to other contagions. Dr. Daniel Fagbuyi, a war veteran and former Obama administration biodefense appointee, joined Cheddar News to discuss the ongoing danger of COVID-19 on top of the war, as well as the potential for new variants to emerge. "I mean just large volumes of people definitely is a breeding ground. That's the worst case," he said. "Two things don't mix: war-conflict and a virus, a potential pandemic virus."
Medical cannabis company Akanda went public this week in what was the first traditional IPO of the month. Shares jumped about 163% in the stock's first day of trading. The London-based company says it hopes to supply medical cannabis products to wholesalers in international markets. Tej Virk, CEO of Akanda, joins Cheddar News' Closing Bell to discuss.
Bioscience and genetic engineering company, Colossal, raised $60 million in a Series A funding round. Colossal is focused on developing new technologies and genetic tools to restore extinct species, and protect critically endangered species. One of the startup's long-term goals is to resurrect the woolly mammoth, and return it back to the arctic. Colossal also says it is developing technology that expands beyond animals, and has the potential to advance human health. Ben Lamm, co-founder and CEO of Colossal, joins Cheddar News' Closing Bell to discuss.
Residents were cleaning their homes Thursday after a 7.4-magnitude earthquake struck off the coast of Fukushima in northern Japan, smashing furniture, knocking out power and killing four people.
A New Zealand couple who believed they had dug up the world’s largest potato had their dreams turned to mash after Guinness World Records wrote to say that scientific testing had found it wasn’t, in fact, a potato after all.
